XLHED Clinical Trial Opens New Site in Los Angeles
Cedars-Sinai Medical Center in LA added to Edelife Clinical Trial for XLHED, offering prenatal treatment for boys affected by x-linked hypohidrotic ectodermal dysplasia. This marks the second US location, aiming for 15-20 participants, with the trial also available in Europe. Led by Dr. Ophir Klein, the trial seeks to confirm the safety and efficacy of ER-004, a potential first-of-its-kind medicine for structural birth defects, with all associated expenses covered for participating families.
Highlighted Terms
Related News
Cedars-Sinai Medical Center in LA added to Edelife Clinical Trial for XLHED, offering prenatal treatment for boys affected by x-linked hypohidrotic ectodermal dysplasia. This marks the second US location, aiming for 15-20 participants, with the trial also available in Europe. Led by Dr. Ophir Klein, the trial seeks to confirm the safety and efficacy of ER-004, a potential first-of-its-kind medicine for structural birth defects, with all associated expenses covered for participating families.